New idol for cholesterol reduction?

Clinical Chemistry

Volumn 55, Issue 12, 2009, Pages 2082-2084

  Sawamura, Tatsuya ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER X RECEPTOR AGONIST; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITOR; STEROL REGULATORY ELEMENT BINDING PROTEIN; TORCETRAPIB;

ADRENAL DISEASE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CORONARY ARTERY DISEASE; ENDOPLASMIC RETICULUM; FAMILIAL HYPERCHOLESTEROLEMIA; GOLGI COMPLEX; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; NONHUMAN; SHORT SURVEY;

ANIMALS; CHOLESTEROL; HUMANS; MICE; ORPHAN NUCLEAR RECEPTORS; RECEPTORS, LDL; SERINE ENDOPEPTIDASES; TRANSCRIPTION, GENETIC; UBIQUITIN-PROTEIN LIGASES;

EID: 71749098578     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.134023     Document Type: Short Survey

References (5)

1. Zelcer N, Hong C, Boyadjian R, Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science (Wash DC) 2009;325:100-104
2. DeBose-Boyd RA. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res 2008;18:609-621
3. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990;343:425-430
4. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol 2001;21:1712-1719 (Pubitemid 34219772)
5. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006;354:1264-1272